MLICM
CORZ

Metropolitan Life Insurance Company (MetLife)’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,513
Closed -$22.8K – 2380
2022
Q3 		$22.8K Buy
17,513
+3,274
+23% +$6.97K ﹤0.01% 1966
2022
Q2 		$21.2K Buy
+14,239
New +$65.4K ﹤0.01% 2027

Other funds holding CORZ

PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $6.36B AUM 28.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
STA
Summit Trail Advisors New York $7.95B AUM 26.49% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CORZ Position: Q4 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Core Scientific, Inc. Common Stock (CORZ) in Q4 2022, closing a stake of 17,513 shares — an estimated $22.8K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CORZ in Q2 2022 and held it in 2 quarters. The position peaked at $22.8K in Q3 2022. 89 funds tracked by Wall St. Rank hold CORZ as of Q4 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Core Scientific, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 17,513 Core Scientific, Inc. Common Stock shares in Q4 2022, an estimated $22.8K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Core Scientific, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Core Scientific, Inc. Common Stock position peaked at $22.8K in Q3 2022.
  • 89 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q4 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2022, filed 15 Feb 2023.